World Journal of
Pharmaceutical and Life Sciences

DISCOVERING THE COMBINED IN-VITRO ANTI-INFLAMMATORY EFFECTS OF SMILAX GLABRA STANDARDIZED RHIZOME EXTRACT AND BERBERIS ARISTATA STANDARDIZED ROOT EXTRACT

Vikram Singh*

ABSTRACT

No combined anti-inflammatory perspectives of Smilax glabra rhizome extract and Berberis aristata root extract have been described in an in vitro approach, according to a search of standard worldwide scientific and pharmaceutical databases (human red blood cells, HRBC). S. glabra standardized rhizome extract (SGSRE) and B. aristata standardized fruit extract (BASFE) were tested combined to see whether they had any synergistic action. At a concentration of 250 ?g/mL, SGSRE provided 28.63 percent membrane stabilization/protection in HRBCs, whereas BASFE provided 38.11 percent. When the extracts SGSRE and BASFE were combined (at a concentration of 250 ?g/mL each), their anti-inflammatory effect was increased to 58.14 percent. The anti-inflammatory impact was boosted by 20 percent to 30 percent when both extracts were given at the same time. Saponin, tannin, terpenoid, flavonoid, alkaloid, steroid, phenolics, and other phytoconstituents found in plants mediate anti-inflammatory effects by inhibiting various inflammatory enzymes and helping to stabilize the HRBC membrane. This study will open the door for further research into developing new herbal formulations to treat acute and chronic inflammation.

[Full Text Article]   [Download Certificate]